Advanced grinding technology for biomedical research
Planetary Ball Mill with Cell Disruptor Capability
This study is testing a special machine that helps break down plant materials and cells faster and more effectively, which could lead to better medicines and useful plant compounds for health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Morgan State University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10880924 on NIH RePORTER |
What this research studies
This research focuses on acquiring a high-frequency specimen grinder, the Planetary Ball Mill model PM200, which has the capability to disrupt cells and process plant materials efficiently. By utilizing mechanical forces instead of chemical compounds, this instrument aims to enhance the speed and effectiveness of specimen grinding and cell lysis, which are crucial for various biomedical applications. The research will support the development of new drug formulations and the extraction of beneficial phytochemicals, ultimately advancing the field of biomedical research.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals involved in biomedical research, particularly those studying drug development and phytochemistry.
Not a fit: Patients who are not engaged in biomedical research or do not have a direct interest in drug formulation or phytochemical extraction may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more efficient drug formulations and the discovery of new anti-cancer compounds from plants.
How similar studies have performed: Other research has shown success with similar mechanical approaches in specimen processing, indicating a promising avenue for advancements in biomedical applications.
Where this research is happening
Baltimore, United States
- Morgan State University — Baltimore, United States (Active)
Researchers
- Principal investigator: Samokhvalov, Alexandr — Morgan State University
- Study coordinator: Samokhvalov, Alexandr
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.